Susan Ziolkowski is a Nephrology physician affiliated with Palo Alto University. OpenAlex indexes 36 publications with 307 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Pasteur Dr
Stanford, CA 943052200
Telephone
650-723-4000Provider last certified this registry record 24 Apr 2024.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:
- Integrating machine learning to improve kidney disease risk assessment for patients on cancer therapy
Stanford University
FY2026$191,470K23DK141988 - Integrating machine learning to improve kidney disease risk assessment for patients on cancer therapy
Stanford University
FY2025$192,888K23DK141988 - Prevalence and Clinical Significance of Relative Sarcopenia and Excess Adiposity in Adults with Chronic Kidney Disease
Stanford University
FY2018$67,378F32DK111083
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Percent body fat misclassifies patients with sarcopenia as obese: support for fat mass index in obesity assessment
Journal of the Endocrine Society
2026 - WCN26-3938 MINIMAL CHANGE DISEASE ASSOCIATED WITH RIBOCICLIB: A NOVEL RENAL COMPLICATION OF CDK4/6 INHIBITOR THERAPY
Kidney International Reports
2026 - Monoclonal versus monotypic: promoting awareness of terminology and clinical take-aways
Kidney International
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Tait Shanafelt, MD
Palo Alto University
Victor Froelicher, MD
Palo Alto University
Kimford Meador, MD
Palo Alto University
Michael Marmor, MD
Palo Alto University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”